Search Results - Enxiao Li

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non–Small Cell Lung Cancer Cells

    Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non–Small Cell Lung Cancer Cells by Xuyuan Dong, Ester Fernández‐Salas, Enxiao Li, Shaomeng Wang

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma

    PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma by Ke Ma, Xin Wei, Danfeng Dong, Yinying Wu, Qianqian Geng, Enxiao Li

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Tislelizumab Plus Chemotherapy as First-line Treatment for Advanced Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

    Tislelizumab Plus Chemotherapy as First-line Treatment for Advanced Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma by Jianming Xu, Yuxian Bai, Nong Xu, Enxiao Li, Buhai Wang, Jin Wang, Xiang Li, Xin Wang, Xianglin Yuan

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma

    HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma by Haixia Yang, Jiupeng Zhou, Jianqiang Mi, Ke Ma, Yangwei Fan, Jing Ning, Chuying Wang, Xin Wei, Huadong Zhao, Enxiao Li

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors

    Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors by Yangwei Fan, Ke Ma, Chuying Wang, Jing Ning, Yuan Hu, Danfeng Dong, Xuyuan Dong, Qianqian Geng, Enxiao Li, Yinying Wu

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells

    Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibrobla... by Yu Shi, Liankang Sun, Rui Zhang, Yuan Hu, Yinying Wu, Xuyuan Dong, Danfeng Dong, Chen Chen, Zhimin Geng, Enxiao Li, Yangwei Fan

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Incidence and survival differences in esophageal cancer among ethnic groups in the United States

    Incidence and survival differences in esophageal cancer among ethnic groups in the United States by Zheling Chen, Yinghong Ren, Xianglin L. Du, Jiao Yang, Yanwei Shen, Shuting Li, Yunying Wu, Meng Lv, Danfeng Dong, Enxiao Li, Wei Li, Peijun Liu, Jin Yang, Min Yi

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

    Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial by Feng Wang, Shukui Qin, Xinchen Sun, Zhenggang Ren, Zhiqiang Meng, Zhendong Chen, Xiaoli Chai, Jianping Xiong, Yuxian Bai, Lin Yang, Hong Zhu, Weijia Fang, Xiaoyan Lin, Xiaohong Chen, Enxiao Li, Linna Wang, Ping Yan, Jianjun Zou

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma

    Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma by Xi Wang, Chengsheng Zhang, Xuyuan Dong, Yuan Hu, Baojun Duan, Jun Bai, Yinying Wu, Fan Lin, Xin-Hua Liao, Kang Ye, Peng Zhang, Mengyang Li, Jiao Xu, Zhijun Mao, Hui-Tong Liu, Xiaolong Zhang, Lifei Tian, Enxiao Li

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers

    Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers by Zhihao Lu, Mingfei Geng, Yongtao Han, Jianzhong Cao, Jun Wang, Tianshu Liu, Xianglin Yuan, Xue Meng, Yanqiao Zhang, Rong Zhao, Lixin Wan, Enxiao Li, Wenran Wang, Zhijie Li, Danfeng Shi, Jing Qian, Si Shi, Fengshi Dong, Lin Shen

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

    Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial by Jianming Xu, Jie Shen, Shanzhi Gu, Yun Zhang, Lihua Wu, Jian Wu, Guoliang Shao, Yanqiao Zhang, Li Xu, Tao Yin, Jingfeng Liu, Zhenggang Ren, Jianping Xiong, Xianhai Mao, Ling Zhang, Jiayin Yang, Le‐Qun Li, Xiaohong Chen, Zhiming Wang, Kangsheng Gu, Xi Chen, Zhanyu Pan, Kuansheng Ma, Xinmin Zhou, Zujiang Yu, Enxiao Li, Guowen Yin, Xiao Zhang, Shuni Wang, Quanren Wang

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

    Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer:... by Zhi Peng, Tianshu Liu, Jia Wei, Airong Wang, Yifu He, Liuzhong Yang, Xizhi Zhang, Nanfeng Fan, Suxia Luo, Zhen Li, Kangsheng Gu, Jianwei Lu, Jianming Xu, Qingxia Fan, Rui‐Hua Xu, Liangming Zhang, Enxiao Li, Yuping Sun, Guohua Yu, Chunmei Bai, Yong Liu, Jiangzheng Zeng, Jieer Ying, Xinjun Liang, Nong Xu, Chao Gao, Yongqian Shu, Dong Ma, Guanghai Dai, Shengmian Li, Ting Deng, Yuehong Cui, Jianmin Fang, Yi Ba, Lin Shen

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition)

    Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition) by Jian Li, Ying Yuan, Fan Yang, Yi Wang, Xu Zhu, Zhenghang Wang, Shu Zheng, Desen Wan, Jie He, Jianping Wang, Yi Ba, Chunmei Bai, Li Bai, Wei Bai, Feng Bi, Kaican Cai, Muyan Cai, Sanjun Cai, Gong Chen, Ke‐Neng Chen, Lin Chen, Pengju Chen, Pan Chi, Guanghai Dai, Yanhong Deng, Kefeng Ding, Qingxia Fan, Weijia Fang, Xuedong Fang, Feng-yi Feng, Chuangang Fu, Qihan Fu, Gu Yanhong, Yulong He, Baoqing Jia, Kewei Jiang, Maode Lai, Ping Lan, Enxiao Li, Dechuan Li, Jin Li, Leping Li, Ming Li, Shaolei Li, Ye‐Xiong Li, Yongheng Li, Zhongwu Li, Xiaobo Liang, Zhiyong Liang, Feng Lin, Guole Lin, Hongjun Liu, Jianzhong Liu, Tianshu Liu, Yunpeng Liu, Hongming Pan, Zhizhong Pan, Haiping Pei, Meng Qiu, Xiujuan Qu, Li Ren, Zhanlong Shen, Weiqi Sheng, Chun Song, Lijie Song, Jianguo Sun, Lingyu Sun, Ying‐Shi Sun, Yuan Tang, Min Tao, Chang Wang, Haijiang Wang, Jun Wang, Shubin Wang, Xicheng Wang, Xishan Wang, Ziqiang Wang, Aiwen Wu, Nan Wu, Lijian Xia, Yi Xiao, Baocai Xing, Bin Xiong, Jianmin Xu, Jianming Xu, Nong Xu, Rui‐Hua Xu, Zhongfa Xu, Yue Yang, Hongwei Yao, Yingjiang Ye, Yonghua Yu, Yue‐Ming Yu, Jinbo Yue, Jingdong Zhang, Jun Zhang, Suzhan Zhang, Wei Zhang, Yanqiao Zhang, Zhen Zhang

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: